On June 27, 2013, a federal judge found clear evidence that the U.S. Food & Drug Administration would not have approved a strong warning label for Merck & Co. Inc.'s Fosamax link to femur fractures.
Law360 talks to Bowman and Brooke's Randy Christian.
Read the Law360 article.